Showing results (571-580 of 11,696) with videos related to

Sort By:
Pageof 1,170
European Heart Journal|February 8, 2011
Myocardial ischaemia and viability: the pivotal role of echocardiographyPetros Nihoyannopoulos, Jean Louis Vanoverschelde
European Heart Journal|February 25, 2011
EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary interventionMaarten de Mulder, Anselm Gitt, Ron van Domburg, et al.
European Heart Journal|January 29, 2011
In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomographyTaishi Yonetsu, Tsunekazu Kakuta, Tetsumin Lee, et al.
European Heart Journal|January 13, 2011
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerabilityFabrizio Montecucco, Nicolas Vuilleumier, Sabrina Pagano, et al.
European Heart Journal|January 4, 2011
Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblastsMasayoshi Iwasaki, Masamichi Koyanagi, Hans Kossmann, et al.
European Heart Journal|January 4, 2011
Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and WalesRobert M West, Brian A Cattle, Marianne Bouyssie, et al.
European Heart Journal|January 4, 2011
High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarctionWalter Desmet, Jan Bogaert, Christophe Dubois, et al.
European Heart Journal|December 25, 2010
Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditisS Van Linthout, K Savvatis, K Miteva, et al.
European Heart Journal|August 1, 1990
Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectorisM van den Brand, C van Halem, F van den Brink, et al.
European Heart Journal|January 7, 2011
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trialBertram Pitt, Stefan D Anker, David A Bushinsky, et al.
Pageof 1,170